Wenyan Cheng

526 total citations
13 papers, 74 citations indexed

About

Wenyan Cheng is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Wenyan Cheng has authored 13 papers receiving a total of 74 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 5 papers in Molecular Biology and 4 papers in Genetics. Recurrent topics in Wenyan Cheng's work include Acute Myeloid Leukemia Research (10 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers) and Single-cell and spatial transcriptomics (2 papers). Wenyan Cheng is often cited by papers focused on Acute Myeloid Leukemia Research (10 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers) and Single-cell and spatial transcriptomics (2 papers). Wenyan Cheng collaborates with scholars based in China and United States. Wenyan Cheng's co-authors include Yang Shen, Yongmei Zhu, Tingting Ma, Yan Han, Fujia Liu, Shiyang Wang, Yu‐Jun Dai, Yi Hu, Bing Chen and Sai‐Juan Chen and has published in prestigious journals such as Blood, Advanced Functional Materials and Annals of Oncology.

In The Last Decade

Wenyan Cheng

11 papers receiving 74 citations

Peers

Wenyan Cheng
Stephanie M. Kapsalis United States
Jason Van Oostendorp United Kingdom
Georgia Andrew United States
Caroline Almon United States
Louise MacGillivray United Kingdom
Lisa Gu United States
Stephanie M. Kapsalis United States
Wenyan Cheng
Citations per year, relative to Wenyan Cheng Wenyan Cheng (= 1×) peers Stephanie M. Kapsalis

Countries citing papers authored by Wenyan Cheng

Since Specialization
Citations

This map shows the geographic impact of Wenyan Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenyan Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenyan Cheng more than expected).

Fields of papers citing papers by Wenyan Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenyan Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenyan Cheng. The network helps show where Wenyan Cheng may publish in the future.

Co-authorship network of co-authors of Wenyan Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Wenyan Cheng. A scholar is included among the top collaborators of Wenyan Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenyan Cheng. Wenyan Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Li, Hongjun, Wenyan Cheng, Minglei Shi, et al.. (2025). HemaScope: A Tool for Analyzing Single-cell and Spatial Transcriptomics Data of Hematopoietic Cells. Genomics Proteomics & Bioinformatics. 23(2). 1 indexed citations
2.
Dai, Yuting, Wen Jin, Wenyan Cheng, et al.. (2025). Resolving Leukemia Heterogeneity and Lineage Aberrations with HematoMap. Genomics Proteomics & Bioinformatics. 23(2).
3.
Chen, Wenwen, Wenyan Cheng, Kuixing Ding, et al.. (2025). Pyridinic‐N‐Cu‐Se Interfacial Synergy Enables Stable Bifunctional Oxygen Electrocatalysis. Advanced Functional Materials. 36(16). 1 indexed citations
4.
Jin, Peng, Jianfeng Li, Hongming Zhu, et al.. (2024). NAD metabolism-related genes provide prognostic value and potential therapeutic insights for acute myeloid leukemia. Frontiers in Immunology. 15. 1417398–1417398.
5.
Cheng, Wenyan, Yuliang Zhang, T.F. Sun, et al.. (2023). Identification of IKZF1 genetic mutations as new molecular subtypes in acute myeloid leukaemia. Clinical and Translational Medicine. 13(6). e1309–e1309. 5 indexed citations
7.
Zhu, Hongming, Wenyan Cheng, Xinjie Chen, et al.. (2023). Clinical Characteristics, Genetic Profile and Prognosis of Adult Acute Myeloid Leukemia with NUP98 Rearrangement. Blood. 142(Supplement 1). 2867–2867. 2 indexed citations
8.
9.
Liu, Fujia, Wenyan Cheng, Shiyang Wang, et al.. (2021). Measurable Residual Disease Detected by Multiparameter Flow Cytometry and Sequencing Improves Prediction of Relapse and Survival in Acute Myeloid Leukemia. Frontiers in Oncology. 11. 677833–677833. 7 indexed citations
10.
Ma, Tingting, Wenyan Cheng, Shiyang Wang, et al.. (2020). Development and validation of a prognostic model for adult patients with acute myeloid leukaemia. EBioMedicine. 62. 103126–103126. 10 indexed citations
11.
Cheng, Wenyan, et al.. (2019). Genetic alteration patterns and clinical outcomes of elderly and secondary acute myeloid leukemia. Hematological Oncology. 37(4). 456–463. 10 indexed citations
12.
Xie, Dong, et al.. (2019). [Correlation between myeloperoxidase expression and gene alterations and prognosis in acute myeloid leukemia].. PubMed Central. 40(1). 40–45. 5 indexed citations
13.
Zhu, Yongmei, Jinyan Huang, Bing Chen, et al.. (2017). Gene mutational pattern and expression level in 560 acute myeloid leukemia patients and their clinical relevance. Journal of Translational Medicine. 15(1). 178–178. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026